Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Mannatech Expands Product Offering in Colombia, Providing Additional Wellness Solutions for Families

Posted on: 16 Nov 16

Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced it will launch five new products to its Associates and customers in Colombia at its “Empowerment” event, November 18-19 in Bogota.

This product launch and event is a part of Mannatech’s CEO and President, Al Bala’s vision for bringing Mannatech’s high-quality Polysaccharide-based technologies into Latin America which represents a market with a growing middle class that is concerned for their family’s health and wellness.

“The Colombia market continues to show momentum, and our Associates and customers are excited to add new Mannatech products to their health and wellness regimen,” said Mannatech’s CEO and President, Alfredo “Al” Bala. “We are thrilled to bring new health and wellness solutions to the people of Colombia, and we are committed to providing them with the best products on the market.”

The new health, wellness and skincare products being introduced in Colombia include Emprizone®, a hydrating skincare gel; I-START®, a colostrum supplement that helps support the immune system; and Omega-3 with Vitamin D3, a dietary supplement to support strong bones and heart health.

These new products pair well with the existing products offered in Colombia, which include MannaTea™, an herbal tea concentrate; GI-ProBalance™ Slimsticks, a probiotic and prebiotic supplement; and MannaBears™, a tasty and natural gummy bear. These products are based on Mannatech’s pioneering Polysaccharide technology, which was formulated to support communication on the cellular level.

These products will be introduced and unveiled at Mannatech Colombia’s “Empowerment” event on Saturday, November 19 from 10 a.m. to 6 p.m. at Hall 74, Centro de Events, located at Calle 74 No. 14-25, Bogota, Colombia. Mannatech executives, staff and Associates will lead the event and guests are invited to attend.

To begin changing your life or the lives of those around you, please visit

About Mannatech

Mannatech, Incorporated, offers a profound wellness experience through a financially rewarding opportunity that makes a difference in the lives of people across the world. Through its innovative glyconutrition products, Mannatech changes lives, providing an unprecedented level of natural wellness, freedom and purpose. With more than 20 years of experience and operations in 25 countries, Mannatech is committed to changing lives. For more information, visit

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

View source version on

Business Wire

Last updated on: 16/11/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.